Saqib Islam
CIK 1575408 · Chief Executive Officer · last filed 2026-06-26
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
SWTX price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
352 KNOTTER DRIVE
CHESHIRE, CT 06410
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SPRY | Director | — | $3.90 | — | $0 | 4 | 2026-06-26 |
| SpringWorks Therapeutics, Inc. (SWTX) Delisted | Chief Executive Officer | 0 | $46.99 | $0 | -$31.21M | 25 | 2025-07-02 |
| PASG | Director | 250 | $3.31 | $828 | $90.0K | 7 | 2025-05-30 |
| ARS Pharmaceuticals, Inc. (SBTX) Delisted | Director | — | $5.87 | — | $0 | 3 | 2022-06-13 |
Recent Filings · Page 5 of 6
54 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-03-03 | PASG | Buy (P) | +5,000 | $90.0K | EDGAR |
| 2020-03-02 | PASG | Grant (A) | — | $0 | EDGAR |
| 2016-03-01 | — | Sell (S) | −905 | -$125.7K | |
| 2016-02-08 | — | Mixed | +8,319 | -$486.2K | |
| 2015-12-08 | — | Sell (S) | −950 | -$180.5K | |
| 2015-11-04 | — | Sell (S) | −975 | -$175.5K | |
| 2015-10-29 | — | Sell (S) | −1,558 | -$262.4K | |
| 2015-04-30 | — | Sell (S) | −6,032 | -$1.10M | |
| 2015-03-03 | — | Mixed | +4,872 | -$41.1K | |
| 2015-02-12 | — | Sell (S) | −1,500 | -$256.7K |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.